易明医药：关于购买董事、高级管理人员责任险的公告

Core Viewpoint - Yiming Pharmaceutical announced plans to purchase liability insurance for its directors and executives, with a compensation limit not exceeding 100 million yuan and a premium not exceeding 500,000 yuan for a duration of 12 months [2] Group 1 - The company intends to seek shareholder approval to authorize the management team to handle the insurance purchase and renewal matters [2]